Chinese Journal of Pharmacovigilance ›› 2020, Vol. 17 ›› Issue (11): 803-807.
DOI: 10.19803/j.1672-8629.2020.11.12

Previous Articles     Next Articles

Analysis of 182 Case of Serious Adverse Drug Reactions/events Reports in a Hospital

WU Wenli1, JING Jing1, LU Zhaogang1, ZANG Guixiang2, WANG Jian1, WANG Xiaoxu1, WANG Jiyun1,*   

  1. 1Department of Clinical Pharmacy, People's Hospital of Ningxia Hui Autonomous Region /First Affiliated Hospital of Northwest University for Nationalities, Yinchuan Ningxia 750021,China;
    2Department of Endocrinology, People's Hospital of Ningxia Hui Autonomous Region /First Affiliated Hospital of Northwest University for Nationalities, Yinchuan Ningxia 750021, China
  • Received:2020-11-10 Revised:2020-11-10 Online:2020-11-15 Published:2020-11-10

Abstract: Objective To analyze the characteristics of serious adverse drug reactions/events (ADR/AE) reported in one hospital so as to provide reference for rational drug use in clinical practice. Methods One hundred and eighty-two reports of serious ADR/AE in one hospital were retrospectively analyzed, while drug categories, routes of administration, prognosis, systems or organs involved and clinical manifestations were studied. Results Among the 182 cases, 90 were males and 92 were females, and the group aged 15 to 44 accounted for 35.71%. According to categories, antimicrobial drugs ranked first (28.04%), followed by Chinese patent medicines and central nervous system drugs. Hepatobiliary disorders, general disorders, skin and appendages disorders were the most common involved systems organ classes(SOCs). The main clinical manifestations were abnormal hepatic function, increased hepatic enzymes, and anaphylactic shock. Conclusion Antimicrobial drugs and Chinese patent medicines remain the focus of monitoring of serious ADR/AE. Patients over 45 years old who have taken more than one drug for a long time should be monitored for liver and kidney function to ensure medication safety.

Key words: adverse drug reactions(ADR), adverse drug events(AE), serious, Safe medication

CLC Number: